Pleurodesis
• obliteration of the pleural space by inducing
adherence of the visceral and parietal layers
• by the use of sclerosing agents or surgical
abrasion
• to treat recurrent pneumothorax or
malignant pleural effusion
Prognostic factors for successful
chemical pleurodesis
• Pleural fluid pH
- pH > 7.2
• Glucose level
- glucose > 60mg/dl
• Changes in pleural pressure during
thoracentesis
Mechanism of pleurodesis
• A tight and complete apposition between the
two pleural layers
• Following intrapleural application of the
sclerosing agent,
- diffuse inflammation
- pleural coagulation-fibrinolysis imbalance
(favoring the formation of fibrin adhesions)
- recruitment and subsequent proliferation of
fibroblasts, and collagen production.
• The pleural mesothelial lining is the primary
target for the sclerosant and causes the
release of several mediators :
- interleukin-8,
- transforming growth factor-β (TGF-β)
- basic fibroblast growth factor.
• talc can induce apoptosis in tumor cells and
inhibit angiogenesis, thus contributing to a
better control of the malignant pleural
effusion.
• Talc
- Insufflated or slurry
- Adv. - Widely available, inexpensive, effective
- Ass. with development of ARDS (more
common if smaller talc particles are used)
• Tetracycline derivatives
- Doxycycline, minocycline
- Side effect – severe chest pain
- Give lorazepam/midazolam and systemic pain
medications before inj.
Choice of sclerosing agent
• Antineoplastic agents
- Bleomycin – less effective than talc or
tetracycline derivatives , expensive
- Nitrogen mustard –better than bleomycin ,
cheaper
- Mitoxantrone –
Adv- binds to cell membranes & remain in
pleural space longer
Side effect- cardiotoxicity
• Silver nitrate
- Very effective
- Recurrence of effusion is less
- At high conc. – severe side effects.
• Iodopovidone
- 100ml of 2% iodopovidone
- Side effects – intense pleuritic pain, systemic
hypotension.
• Other agents
- Dried killed Corynebacterium parvum
- OK-432
- Quinacrine
Agent of choice:
-Malignant pleural effusion treated with tube
thoracostomy – doxycycline 500mg or
tetracycline 1500mg or minocycline 300mg
-Malignant pleural effusion diagnosed during
thoracoscopy or at thoracotomy – pleural
abrasion or parietal pleurectomy
Intrapleural injection of sclerosing
agent
• Performed by injecting sclerosant through a
chest tube
• Size of chest tube – no effect
• Chest tube connected to a water-sealed
drainage system
• The effusion is allowed to drain
• Sclerosant injected as soon as lung has
expanded
• If lung not expand with tube thoracostomy,
pleural fluid can be drained with:
- PleurX catheter
- Pleuroperitoneal shunt
• Catheter then flushed with 50-100ml of saline
• Chest tube is clamped for at least 1 hr.
• Patient is rotated
• Unclamp the chest tube and apply negative
pressure
• Suction is maintained for 24hrs until pleural
drainage <150ml/day.
• Chest tube removed after 96 hrs
• In outpatient basis
- PleurX
- Gravity drainage system of Patz
• Facilitates home drainage for suitable
ambulatory patients
• Provides relief while avoiding hospitalization
Thoracoscopy for pleurodesis
• If thoracoscopy is performed for an
undiagnosed recurrent pleural effusion –
induce a pleurodesis
• Best method : mechanical abrasion of pleura
• Alternatives- intrapleural instillation of 2%
iodopovidone, intrapleural instillation of
collagen.
• Insufflation of talc- can cause resp. failure and
death
Alternatives treatment
• Symptomatic treatment
- chest pain – analgesics
- Dyspnea – opiates or oxygen
• Periperitoneal shunt
- In pt. whom lung does not expand after tube
thoracoscopy , pleurodesis has failed
- Also if chylothorax is present
- adv.
i. Less hosp. time
ii.Less pain
iii.Can be performed on outpatient basis
iv.Pt may benefit psychologically from using the
pump when he is dyspneic
- disadv.
i. Shunt becomes obstructed
ii.Insertion requires gen. anaesthesia
iii.Must be inserted by a surgeon
iv.Must use the pump daily
• Pleurectomy
1.In pt who undergoes a diagnostic
thoracotomy for an undiagnosed pleural
effusion
- If malignant disease is found – parietal
pleurectomy
2.Symp. pt with a persistent pleural effusion and
trapping of ipsilateral lung
- Decortication of the trapped lung and parietal
pleurectomy
• Thoracentesis
- For symptomatic relief
- Req. frequent visit to physician
- Can lead to loculation of the pleural fluid

Pleurodesis

  • 1.
  • 2.
    • obliteration ofthe pleural space by inducing adherence of the visceral and parietal layers • by the use of sclerosing agents or surgical abrasion • to treat recurrent pneumothorax or malignant pleural effusion
  • 3.
    Prognostic factors forsuccessful chemical pleurodesis • Pleural fluid pH - pH > 7.2 • Glucose level - glucose > 60mg/dl • Changes in pleural pressure during thoracentesis
  • 4.
    Mechanism of pleurodesis •A tight and complete apposition between the two pleural layers • Following intrapleural application of the sclerosing agent, - diffuse inflammation - pleural coagulation-fibrinolysis imbalance (favoring the formation of fibrin adhesions) - recruitment and subsequent proliferation of fibroblasts, and collagen production.
  • 5.
    • The pleuralmesothelial lining is the primary target for the sclerosant and causes the release of several mediators : - interleukin-8, - transforming growth factor-β (TGF-β) - basic fibroblast growth factor. • talc can induce apoptosis in tumor cells and inhibit angiogenesis, thus contributing to a better control of the malignant pleural effusion.
  • 6.
    • Talc - Insufflatedor slurry - Adv. - Widely available, inexpensive, effective - Ass. with development of ARDS (more common if smaller talc particles are used) • Tetracycline derivatives - Doxycycline, minocycline - Side effect – severe chest pain - Give lorazepam/midazolam and systemic pain medications before inj. Choice of sclerosing agent
  • 7.
    • Antineoplastic agents -Bleomycin – less effective than talc or tetracycline derivatives , expensive - Nitrogen mustard –better than bleomycin , cheaper - Mitoxantrone – Adv- binds to cell membranes & remain in pleural space longer Side effect- cardiotoxicity
  • 8.
    • Silver nitrate -Very effective - Recurrence of effusion is less - At high conc. – severe side effects. • Iodopovidone - 100ml of 2% iodopovidone - Side effects – intense pleuritic pain, systemic hypotension.
  • 9.
    • Other agents -Dried killed Corynebacterium parvum - OK-432 - Quinacrine
  • 10.
    Agent of choice: -Malignantpleural effusion treated with tube thoracostomy – doxycycline 500mg or tetracycline 1500mg or minocycline 300mg -Malignant pleural effusion diagnosed during thoracoscopy or at thoracotomy – pleural abrasion or parietal pleurectomy
  • 11.
    Intrapleural injection ofsclerosing agent • Performed by injecting sclerosant through a chest tube • Size of chest tube – no effect • Chest tube connected to a water-sealed drainage system • The effusion is allowed to drain • Sclerosant injected as soon as lung has expanded
  • 12.
    • If lungnot expand with tube thoracostomy, pleural fluid can be drained with: - PleurX catheter - Pleuroperitoneal shunt • Catheter then flushed with 50-100ml of saline • Chest tube is clamped for at least 1 hr. • Patient is rotated • Unclamp the chest tube and apply negative pressure
  • 13.
    • Suction ismaintained for 24hrs until pleural drainage <150ml/day. • Chest tube removed after 96 hrs • In outpatient basis - PleurX - Gravity drainage system of Patz • Facilitates home drainage for suitable ambulatory patients • Provides relief while avoiding hospitalization
  • 14.
    Thoracoscopy for pleurodesis •If thoracoscopy is performed for an undiagnosed recurrent pleural effusion – induce a pleurodesis • Best method : mechanical abrasion of pleura • Alternatives- intrapleural instillation of 2% iodopovidone, intrapleural instillation of collagen. • Insufflation of talc- can cause resp. failure and death
  • 15.
    Alternatives treatment • Symptomatictreatment - chest pain – analgesics - Dyspnea – opiates or oxygen
  • 16.
    • Periperitoneal shunt -In pt. whom lung does not expand after tube thoracoscopy , pleurodesis has failed - Also if chylothorax is present - adv. i. Less hosp. time ii.Less pain iii.Can be performed on outpatient basis iv.Pt may benefit psychologically from using the pump when he is dyspneic
  • 17.
    - disadv. i. Shuntbecomes obstructed ii.Insertion requires gen. anaesthesia iii.Must be inserted by a surgeon iv.Must use the pump daily
  • 18.
    • Pleurectomy 1.In ptwho undergoes a diagnostic thoracotomy for an undiagnosed pleural effusion - If malignant disease is found – parietal pleurectomy 2.Symp. pt with a persistent pleural effusion and trapping of ipsilateral lung - Decortication of the trapped lung and parietal pleurectomy
  • 19.
    • Thoracentesis - Forsymptomatic relief - Req. frequent visit to physician - Can lead to loculation of the pleural fluid